Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Nuh N. Rahbari

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4703-9039; OpenAlex author ID A5058193717. Sources: OpenAlex.

Their work

Papers
19 (first author 1, last author 5)
Trials
0
Grants
0
Labs led
2
Collaborators
67
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper · 2013: none · 2014: 2 papers · 2015: 1 paper · 2016: 1 paper · 2017: 3 papers · 2018: 1 paper · 2019: none · 2020: 2 papers · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 19

  1. Pancreatic cancer induces B cell lineage plasticity via Pax5 inhibition to sustain immunosuppression. Co-author DOI 10.1038/s41420-026-03174-z↗
  2. Pancreatic cancer patient-derived organoids capture therapy response and tumor evolution Co-author DOI 10.1101/2025.04.24.650216↗
  3. PDCD10 promotes the tumor-supporting functions of TGF-β in pancreatic cancer. Last author DOI 10.1042/cs20240450↗
  4. Structural expression of bovine milk and meat factors in tissues of colorectal, lung and pancreatic cancer patients. Co-author DOI 10.1002/ijc.34374↗
  5. Ultra-sensitive CTC-based liquid biopsy for pancreatic cancer enabled by large blood volume analysis. Last author DOI 10.1186/s12943-023-01880-1↗
  6. Author Correction: Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Co-author DOI 10.1038/s41586-022-05062-9↗
  7. Impact of intraoperative margin clearance on survival following pancreatoduodenectomy for pancreatic cancer: a systematic review and meta-analysis. Last author DOI 10.1038/s41598-020-79252-8↗
  8. Obesity and Pancreatic Cancer: A Matched-Pair Survival Analysis. Co-author DOI 10.3390/jcm9113526↗
  9. Validation of prognostic risk scores for patients undergoing resection for pancreatic cancer. Last author DOI 10.1016/j.pan.2018.05.005↗
  10. Impact of Intraoperative Re-resection to Achieve R0 Status on Survival in Patients With Pancreatic Cancer: A Single-center Experience With 483 Patients. Last author DOI 10.1097/sla.0000000000001808↗
  11. Inhibition of Six1 affects tumour invasion and the expression of cancer stem cell markers in pancreatic cancer. Co-author DOI 10.1186/s12885-017-3225-5↗
  12. Postoperative course and prognostic value of circulating angiogenic cytokines after pancreatic cancer resection. Co-author DOI 10.18632/oncotarget.20315↗
  13. Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy. Co-author DOI 10.1158/2159-8290.cd-15-1177↗
  14. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Co-author DOI 10.1038/nature14581↗
  15. Impact of preoperative diabetes on long-term survival after curative resection of pancreatic adenocarcinoma: a systematic review and meta-analysis. Co-author DOI 10.1245/s10434-013-3415-6↗
  16. Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer. Co-author DOI 10.18632/oncotarget.2651↗
  17. AB0 blood group and prognosis in patients with pancreatic cancer. Co-author DOI 10.1186/1471-2407-12-319↗
  18. Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. First author DOI 10.1097/sla.0b013e31823ac299↗
  19. Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer. Co-author DOI 10.1186/1471-2407-11-286↗

Closest collaborators

The 25 strongest of 67 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christoph Reißfelder · 9 shared papers, 2015–2024 · strength 0.95
  2. Emrullah Birgin · 5 shared papers, 2020–2024 · strength 0.78
  3. Bo Kong · 2 shared papers, 2025–2026 · strength 0.43
  4. Jürgen Weitz · 7 shared papers, 2011–2023 · strength 0.41
  5. Christoph Kahlert · 5 shared papers, 2014–2022 · strength 0.33
  6. Thilo Welsch · 4 shared papers, 2014–2018 · strength 0.26
  7. Qianwen Zhou · 1 shared paper, 2024 · strength 0.26
  8. Felix Rückert · 2 shared papers, 2020 · strength 0.25
  9. Patrick Téoule · 2 shared papers, 2020 · strength 0.25
  10. Ali M. Kassem · 1 shared paper, 2026 · strength 0.24
  11. Hend Abdelrasoul · 1 shared paper, 2026 · strength 0.24
  12. Thomas Wirth · 1 shared paper, 2026 · strength 0.24
  13. Markus Wolfgang Büchler · 4 shared papers, 2011–2023 · strength 0.23
  14. Christian P. Pilarsky · 3 shared papers, 2014–2022 · strength 0.21
  15. Yazid J. Resheq · 1 shared paper, 2025 · strength 0.18
  16. Alica K. Beutel · 1 shared paper, 2025 · strength 0.18
  17. Hans Armin Kestler · 1 shared paper, 2025 · strength 0.18
  18. Élodie Roger · 1 shared paper, 2025 · strength 0.18
  19. Thomas Jens Ettrich · 1 shared paper, 2025 · strength 0.18
  20. Johann Gout · 1 shared paper, 2025 · strength 0.18
  21. André L. Mihaljević · 1 shared paper, 2025 · strength 0.18
  22. Dharini Srinivasan · 1 shared paper, 2025 · strength 0.18
  23. Alexander Kleger · 1 shared paper, 2025 · strength 0.18
  24. Thomas Theodor Werner Seufferlein · 1 shared paper, 2025 · strength 0.18
  25. Christoph W. Michalski · 1 shared paper, 2025 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.